Zofia M. Kiliańska

University of Łódź — Poland

Medicine · Health Sciences

11h-index580citations83works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Chronic Lymphocytic Leukemia Research(24), Acute Lymphoblastic Leukemia research(10), Monoclonal and Polyclonal Antibodies Research(8), Cell death mechanisms and regulation(7), RNA and protein synthesis mechanisms(6)

Publications83 total

Boron Cluster Modifications with Antiviral, Anticancer, and Modulation of Purinergic Receptors’ Activities Based on Nucleoside Structures
2018· 5 cited
Personalized therapy tests for the monitoring of chronic lymphocytic leukemia development
Oncology Letters·2017· 7 citedOpen Access
In vitro antileukemic activity of novel adenosine derivatives bearing boron cluster modification
Bioorganic & Medicinal Chemistry·2016· 20 cited
Relationship between in vitro drug sensitivity and clinical response of patients to treatment in chronic lymphocytic leukemia
International Journal of Oncology·2015· 9 citedOpen Access
Personalized therapy for chronic lymphocytic leukemia
International Journal of Molecular Medicine·2015
Towards the Application of Atorvastatin to Intensify Proapoptotic Potential of Conventional Antileukemic Agents <i>In Vitro</i>
Journal of Chemistry·2015Open Access
The differences in thermal profiles between normal and leukemic cells exposed to anticancer drug evaluated by differential scanning calorimetry
Journal of Thermal Analysis and Calorimetry·2014· 17 citedOpen Access
Responses of CLL Cells to Purine Analogs with Cyclophosphamide
2014
In vivo and ex vivo responses of CLL cells to purine analogs combined with alkylating agent
Pharmacological Reports·2013· 4 cited
Promising anti-leukemic activity of atorvastatin
Oncology Reports·2013· 9 citedOpen Access
Toward personalized therapy for chronic lymphocytic leukemia
Cancer Biology & Therapy·2013· 7 citedOpen Access
Targeting Bcl-2 in CLL
Current Medicinal Chemistry·2012· 11 cited
Lipoprotein lipase; a new prognostic factor in chronic lymphocytic leukemia
Współczesna Onkologia·2012· 7 citedOpen Access
Puma, a critical mediator of cell death — one decade on from its discovery
Cellular & Molecular Biology Letters·2012· 127 citedOpen Access
Can ex vivo evaluation (testing) predict the sensitivity of CLL cells to therapy with purine analogs in conjunction with an alkylating agent? A comparison of in vivo and ex vivo responses to treatment
Medical Oncology·2011· 4 cited
Main Pro-Apoptotic Member of Bcl-2 Family Proteins – Bax
Acta Universitatis Lodziensis Folia Biologica et Oecologica·2010· 3 citedOpen Access
Usefulness of Differential Scanning Calorimetry for Monitoring Ex Vivo the Changes In Responses of CLL Cells to Anti-Cancer Drugs: Development of Personalized Therapy
Blood·2010· 2 cited
Potential New Agents for Chronic Lymphocytic Leukemia Treatment
Anti-Cancer Agents in Medicinal Chemistry·2010· 6 cited
[Biological activity of poly(ADP-ribose)polymerase-1].
PubMed·2010· 8 cited
[Role of heat shock proteins in cell apoptosis].
PubMed·2010· 13 cited
page 1 of 5Next →

Frequent Co-authors

Tadeusz Robak(17), Jerzy Z. Błoński(17), Małgorzata Rogalińska(13), Wanda M. Krajewska(13), L Kłyszejko-Stefanowicz(11), Jolanta D. Żołnierczyk(9), Paweł Góralski(8), Henryk Piekarski(8), Anna Lipińska(8), Zbigniew Wałaszek(6), Józefa Węsierska‐Gądek(6), Paweł Robak(5), Margaret Hanausek(4), Piotr Smolewski(4), Barbara Cebula‐Obrzut(4), Jolanta Bednarek(4), Arleta Kaźmierczuk(3), Oxana Komina(3), Agnieszka Kobylińska(3), Piotr Szymczyk(3)